Compare Eli Lilly And Co (LLY) vs ZIM Integrated Shipping Services Ltd (ZIM) Price & Performance

Eli Lilly (LLY) trades at $1,150.86, down 2.39% on the day, with a bullish technical signal from moving averages and strong fundamental performance. The company reported robust earnings beats in recent quarters, with Q1 2026 EPS of $8.55 exceeding expectations by 23%. Revenue surged to $65.18 billion in 2025, driving a net income margin of 34.99%. Recent news highlights LLY's $2.8 billion acquisition of AtaiBeckley to expand its neuroscience pipeline, signaling strategic growth in mental health treatments.

Outlook remains positive with analyst consensus price target of $1,380 implying 20% upside, supported by 73% buy ratings. Key risks include high valuation multiples (P/E 41.89) and rising debt levels, though operating cash flow growth to $16.81 billion in 2025 provides financial flexibility. Investors should monitor Q2 2026 earnings on August 5 for continued execution on weight-loss drug demand and integration of recent acquisitions.

ZIM Integrated Shipping Services trades at $24.31, showing minimal daily movement with a 0.04% gain. The stock faces bearish technical signals and mixed analyst sentiment, with equal hold and sell ratings. Recent financials show declining revenue from $6.9B in 2025 to $6.3B projected for 2026, while net income dropped sharply from $479M to $98M. The company maintains strong cash flow from operations but faces challenges from regulatory setbacks in the Hapag-Lloyd acquisition and volatile freight rates.

ZIM presents a cautious outlook with significant downside risk to the $16.75 consensus price target. While valuation metrics appear attractive with P/S of 0.47 and P/B of 0.77, declining profitability and regulatory uncertainty offset potential upside. The key opportunity lies in resolution of merger negotiations, while risks include sustained freight rate pressure and ongoing cash burn trends.